PTP1B-IN-1CAS# 612530-44-6 |
2D Structure
- VX-661
Catalog No.:BCC1241
CAS No.:1152311-62-0
- IOWH-032
Catalog No.:BCC3922
CAS No.:1191252-49-9
- CFTRinh-172
Catalog No.:BCC4419
CAS No.:307510-92-5
- GlyH-101
Catalog No.:BCC4104
CAS No.:328541-79-3
- Ivacaftor (VX-770)
Catalog No.:BCC2478
CAS No.:873054-44-5
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 612530-44-6 | SDF | Download SDF |
PubChem ID | 4369452 | Appearance | Powder |
Formula | C8H8N2O3S | M.Wt | 212.23 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Synonyms | PTP1B inhibitor | ||
Solubility | DMSO : ≥ 38 mg/mL (179.05 mM) *"≥" means soluble, but saturation unknown. | ||
Chemical Name | 1,1-dioxo-5-phenyl-1,2,5-thiadiazolidin-3-one | ||
SMILES | C1C(=O)NS(=O)(=O)N1C2=CC=CC=C2 | ||
Standard InChIKey | LDCZCUKQWRZSDT-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C8H8N2O3S/c11-8-6-10(14(12,13)9-8)7-4-2-1-3-5-7/h1-5H,6H2,(H,9,11) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
PTP1B-IN-1 Dilution Calculator
PTP1B-IN-1 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.7119 mL | 23.5593 mL | 47.1187 mL | 94.2374 mL | 117.7967 mL |
5 mM | 0.9424 mL | 4.7119 mL | 9.4237 mL | 18.8475 mL | 23.5593 mL |
10 mM | 0.4712 mL | 2.3559 mL | 4.7119 mL | 9.4237 mL | 11.7797 mL |
50 mM | 0.0942 mL | 0.4712 mL | 0.9424 mL | 1.8847 mL | 2.3559 mL |
100 mM | 0.0471 mL | 0.2356 mL | 0.4712 mL | 0.9424 mL | 1.178 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
PTP1B-IN-1 is a potent protein tyrosine phosphatase-1B (PTP1B) inhibitor with IC50 of 1.6 mM; 1,2,5-thiadiazolidin-3-one-1,1-dioxide scaffold for derivatives synthesis.
References:
[1]. Black E, et al. Structure-based design of protein tyrosine phosphatase-1B inhibitors. Bioorg Med Chem Lett. 2005 May 16;15(10):2503-7.
[2]. Vintonyak VV, et al. Using small molecules to target protein phosphatases. Bioorg Med Chem. 2011 Apr 1;19(7):2145-55.
- AZD1080
Catalog No.:BCC4508
CAS No.:612487-72-6
- Denudadione C
Catalog No.:BCN6608
CAS No.:61240-34-4
- 11-Hydroxybisabola-1,3,5-trien-9-one
Catalog No.:BCN7530
CAS No.:61235-23-2
- 6alpha-Hydroxymaackiain
Catalog No.:BCN3947
CAS No.:61218-44-8
- Uzarigenin digitaloside
Catalog No.:BCN4613
CAS No.:61217-80-9
- Quinine HCl Dihydrate
Catalog No.:BCC4933
CAS No.:6119-47-7
- Grandifloroside
Catalog No.:BCN4133
CAS No.:61186-24-1
- 4-(3,4-Dihydroxyphenyl)-2-butanone
Catalog No.:BCN4132
CAS No.:61152-62-3
- 6alpha-Hydroxymedicarpin
Catalog No.:BCN3939
CAS No.:61135-92-0
- 3,9-Dihydroxypterocarpan
Catalog No.:BCN4131
CAS No.:61135-91-9
- Epipterosin L 2'-O-glucoside
Catalog No.:BCN4614
CAS No.:61117-89-3
- Bromhexine hydrochloride
Catalog No.:BCC8898
CAS No.:611-75-6
- Cannabispiran
Catalog No.:BCN4134
CAS No.:61262-81-5
- Vitexilactone
Catalog No.:BCN4135
CAS No.:61263-49-8
- Acteoside
Catalog No.:BCN4136
CAS No.:61276-17-3
- Boc-D-Phe(4-NO2)-OH
Catalog No.:BCC3276
CAS No.:61280-75-9
- Schizandrin B
Catalog No.:BCN1022
CAS No.:61281-37-6
- Schizandrin A
Catalog No.:BCN1021
CAS No.:61281-38-7
- AKT inhibitor VIII
Catalog No.:BCC1334
CAS No.:612847-09-3
- 2-(Phenylmethoxy)-naphthalene
Catalog No.:BCC8485
CAS No.:613-62-7
- 2-Aminoacetophenone
Catalog No.:BCC8546
CAS No.:613-89-8
- Schisandrin C
Catalog No.:BCN1198
CAS No.:61301-33-5
- Isoacteoside
Catalog No.:BCN4137
CAS No.:61303-13-7
- Boc-D-Arg(Tos)-OH
Catalog No.:BCC3070
CAS No.:61315-61-5